top of page

Turnkey medical cannabis project in Portugal with pre-licenses, EU grant approved, and ready for growth for €550k OBO

Opportunity to acquire a Portuguese turnkey pre-licence project with a 2,000m² facility plan on a 10,000m² plot. Includes pre-licences, strategic location, renegotiated agreements, pre-approved plans, and scalable Spanish and German subsidiaries.

Listing ID:

10228970666

Licence(s) Held:

GMP, GDP, and GADP pre-licenses granted by INFARMED

Portugal flag with a cannabis leaf for a turnkey medical cannabis project.

Seeking outright divestiture of the fully turnkey pre-licence project, company’s subsidiaries, licences and land for €550k OBO

Listing Details:

  • 2,000m² approved construction plan for a state-of-the-art facility on a ~10,000 m² wholly owned plot in Portugal

  • Designed for the pharma-grade extraction market, targeting medical cannabis products such as oral solutions, full-spectrum extracts, oils, and isolates

  • Projected output of ~9 tons of raw material annually on a single shift, with the potential to double production with 3 shifts

  • Defined product lines and secured LOI's for potential offtake to ensure strong demand and market penetration upon launch

  • All necessary production equipment has been pre-negotiated

  • ~€750k invested to date on the project (i.e. architectural, topographic, and engineering)

  • ~€3.5–4 million EU grant with high probability to be approved as have been awarded before

  • Spanish and German subsidiaries included (Note: no active revenues or operations)

  • Layout, architectural design, and basic engineering finalized. A geotechnical survey and detailed engineering are required to complete construction. EPC contract finalised awaiting NTP/contract signing including key CO2 extraction technology package from first class company.

  • An adjoining ~8,000 m² plot has been reserved by the local municipality for potential expansion of the business

  • Company has accumulated approximately €560,000 in tax losses carried forward, which the acquirer can leverage for tax optimization

  • This project offers a rare opportunity to enter the European medical cannabis market with a turnkey project. With substantial groundwork completed, regulatory compliance secured, and a strategic location in Portugal, the foundation for scalable growth is in place

10228970666

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page